scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1043774093 |
P356 | DOI | 10.1007/BF02246074 |
P698 | PubMed publication ID | 8584617 |
P2093 | author name string | J C Winter | |
R A Rabin | |||
D Fiorella | |||
P2860 | cites work | Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. | Q52275732 |
A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. | Q52288652 | ||
Stereospecific requirements for hallucinogenesis. | Q53898878 | ||
Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus. | Q55060522 | ||
Blockade of the stimulus properties of mescaline by a serotonin antagonist | Q66965099 | ||
Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment | Q69351959 | ||
Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids | Q70450611 | ||
Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli | Q70599808 | ||
An hallucinogenic amphetamine analog (DOM) in man | Q71237841 | ||
Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine | Q71435458 | ||
The clinical pharmacology of the hallucinogens | Q79564893 | ||
The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine | Q28296512 | ||
1 Statistical analysis of radioligand assay data | Q30643829 | ||
Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors | Q34163531 | ||
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens | Q34167036 | ||
Functional correlates of serotonin 5-HT1 recognition sites | Q34172554 | ||
2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug | Q34220237 | ||
The Psychopharmacology of Hallucinogenic Agents | Q34221720 | ||
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents | Q34262666 | ||
Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis | Q34555758 | ||
Hallucinogens and serotonergic mechanisms | Q35529455 | ||
Serotonin receptors and their ligands: a lack of selective agents | Q37047684 | ||
Gaps and peculiarities in 5-HT2 receptor studies | Q37783090 | ||
Do classical hallucinogens act as 5-HT2 agonists or antagonists? | Q37783106 | ||
The concept of selectivity in 5-HT receptor research | Q37885973 | ||
LSD. | Q37947862 | ||
Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors | Q39152626 | ||
Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents | Q40156156 | ||
Classical hallucinogens: an introductory overview. | Q41065512 | ||
The stimulus effects of serotonergic hallucinogens in animals | Q41065540 | ||
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone | Q41664184 | ||
Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus | Q41786345 | ||
On the use and abuse of LSD. | Q44646017 | ||
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity | Q44905244 | ||
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist | Q45092262 | ||
The discriminative stimulus properties of LSD: mechanisms of action | Q45170828 | ||
Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine | Q46223306 | ||
Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD). | Q48251635 | ||
Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain | Q48378114 | ||
The use of drug discrimination procedures to characterize hallucinogenic drug actions | Q48394383 | ||
The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states | Q48427090 | ||
Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding | Q48468071 | ||
A characterization of LSD-antagonist effects of pirenperone in the rat. | Q48766654 | ||
Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures | Q49025129 | ||
The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents | Q52208603 | ||
Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats. | Q52249105 | ||
Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. | Q52251139 | ||
P433 | issue | 3 | |
P304 | page(s) | 347-356 | |
P577 | publication date | 1995-10-01 | |
P1433 | published in | Psychopharmacology | Q1422802 |
P1476 | title | The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis | |
P478 | volume | 121 |